Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
3 other identifiers
observational
301
3 countries
81
Brief Summary
RATIONALE: New ways to find out about hearing loss after treatment with chemotherapy may improve the ability to plan cancer treatment and may help patients live more comfortably. PURPOSE: This clinical trial is assessing ear damage in young cancer patients treated with cisplatin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2007
Longer than P75 for all trials
81 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2007
CompletedFirst Posted
Study publicly available on registry
April 11, 2007
CompletedStudy Start
First participant enrolled
May 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2017
CompletedMarch 13, 2017
March 1, 2017
7.7 years
April 9, 2007
March 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Incidence of patients with ototoxicity according to Common Toxicity Criteria, American-Speech-Language-Hearing Association, and Brock's criteria
Length of study
Proportion of patients who undergo assessments using ultrahigh frequency (UHF) and evoked otoacoustic emission (OAE) testing
Length of study
Proportion of patients with complete standard audiometry data (excluding UHF and OAE evaluations)
Length of Study
Study Arms (1)
Ancillary/Correlative (ototoxicity assessment)
Patients undergo hearing tests (conventional, otoscopy, ultrahigh frequency, and otoacoustic emission testing) for management of therapy complications before the first course of planned cisplatin, before each subsequent course of cisplatin, and 4 weeks after the last dose of cisplatin. Patients who are scheduled to receive hematopoietic progenitor stem cell transplantation undergo hearing tests for management of therapy complications before the transplantation and 4 weeks after transplantation.
Interventions
Undergo hearing tests
Eligibility Criteria
Patients planning to undergo treatment with any cisplatin-containing therapeutic regimen for cancer or planning to enroll on clinical trial ACCL0431
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (81)
UAB Comprehensive Cancer Center
Birmingham, Alabama, 35294, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Childrens Hospital Los Angeles
Los Angeles, California, 90027, United States
Southern California Permanente Medical Group
Los Angeles, California, 90027, United States
Children's Hospital Central California
Madera, California, 93638-8762, United States
Lucile Packard Children's Hospital at Stanford University Medical Center
Palo Alto, California, 95798, United States
Rady Children's Hospital - San Diego
San Diego, California, 92123-4282, United States
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, 94115, United States
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
Yale Cancer Center
New Haven, Connecticut, 06520-8028, United States
Alfred I. duPont Hospital for Children
Wilmington, Delaware, 19803, United States
Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, 33901, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, 33136, United States
Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, 32803-1273, United States
Nemours Children's Clinic - Orlando
Orlando, Florida, 32806, United States
Nemours Children's Clinic - Pensacola
Pensacola, Florida, 32504, United States
All Children's Hospital
St. Petersburg, Florida, 33701, United States
St. Joseph's Cancer Institute at St. Joseph's Hospital
Tampa, Florida, 33607, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813, United States
Mountain States Tumor Institute at St. Luke's Regional Medical Center
Boise, Idaho, 83712-6297, United States
University of Illinois Cancer Center
Chicago, Illinois, 60612-7243, United States
Saint Jude Midwest Affiliate
Peoria, Illinois, 61603, United States
Riley's Children Cancer Center at Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Blank Children's Hospital
Des Moines, Iowa, 50309, United States
Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, 52242-1002, United States
Kosair Children's Hospital
Louisville, Kentucky, 40232, United States
Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, 71315-3198, United States
Children's Hospital of New Orleans
New Orleans, Louisiana, 70118, United States
National Naval Medical Center
Bethesda, Maryland, 20889-5600, United States
C.S. Mott Children's Hospital at University of Michigan Medical Center
Ann Arbor, Michigan, 48109-0286, United States
Hurley Medical Center
Flint, Michigan, 48503, United States
Helen DeVos Children's Hospital at Spectrum Health
Grand Rapids, Michigan, 49503, United States
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007-5381, United States
Children's Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis, Minnesota, 55404, United States
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, 55455, United States
Mayo Clinic Cancer Center
Rochester, Minnesota, 55905, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
CCOP - Nevada Cancer Research Foundation
Las Vegas, Nevada, 89109-2306, United States
Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, 07601, United States
Newark Beth Israel Medical Center
Newark, New Jersey, 07112, United States
Carol G. Simon Cancer Center at Morristown Memorial Hospital
Summit, New Jersey, 07901, United States
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87131-5636, United States
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
New York, New York, 10032, United States
SUNY Upstate Medical University Hospital
Syracuse, New York, 13210, United States
New York Medical College
Valhalla, New York, 10595, United States
Presbyterian Cancer Center at Presbyterian Hospital
Charlotte, North Carolina, 28233-3549, United States
Duke Cancer Institute
Durham, North Carolina, 27710, United States
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157-1096, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229-3039, United States
Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106-5000, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205-2696, United States
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, 73104, United States
Legacy Emanuel Children's Hospital
Portland, Oregon, 97227, United States
Knight Cancer Institute at Oregon Health and Science University
Portland, Oregon, 97239-3098, United States
Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania, 18017, United States
Geisinger Cancer Institute at Geisinger Health
Danville, Pennsylvania, 17822-0001, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15213, United States
Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, 02903, United States
Sanford Cancer Center at Sanford USD Medical Center
Sioux Falls, South Dakota, 57117-5039, United States
East Tennessee Children's Hospital
Knoxville, Tennessee, 37916, United States
Driscoll Children's Hospital
Corpus Christi, Texas, 78411, United States
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Dallas, Texas, 75390, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78207, United States
Methodist Children's Hospital of South Texas
San Antonio, Texas, 78229-3993, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042-3300, United States
Children's Hospital of The King's Daughters
Norfolk, Virginia, 23507-1971, United States
Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, 23298-0037, United States
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington, 98105, United States
Providence Cancer Center at Sacred Heart Medical Center
Spokane, Washington, 99220-2555, United States
St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, 54307-3508, United States
Marshfield Clinic - Marshfield Center
Marshfield, Wisconsin, 54449, United States
Princess Margaret Hospital for Children
Perth, Western Australia, 6001, Australia
Children's and Women's Hospital of British Columbia
Vancouver, British Columbia, V6H 3V4, Canada
CancerCare Manitoba
Winnipeg, Manitoba, R3E 0V9, Canada
IWK Health Centre
Halifax, Nova Scotia, B3J 3G9, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Centre Hospitalier Universitaire de Quebec
Québec, Quebec, G1V 4G2, Canada
Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, S7N 4H4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lillian Sung, MD, PhD
The Hospital for Sick Children
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2007
First Posted
April 11, 2007
Study Start
May 1, 2007
Primary Completion
January 1, 2015
Study Completion
February 28, 2017
Last Updated
March 13, 2017
Record last verified: 2017-03